ArticleReviews in cardiovascular medicine2023

Final 36-Month Outcomes from the Multicenter DynamX Study Evaluating a Novel Thin-Strut Novolimus-Eluting Coronary Bioadaptor System and Supporting Preclinical Data.

Stefan Verheye et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.